170 related articles for article (PubMed ID: 15213224)
1. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
3. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
[TBL] [Abstract][Full Text] [Related]
5. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
[TBL] [Abstract][Full Text] [Related]
7. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
8. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
[TBL] [Abstract][Full Text] [Related]
9. 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis.
Ludwig K; Fan H; Dobers J; Berger M; Reutter W; Böttcher C
Biochem Biophys Res Commun; 2004 Jan; 313(2):223-9. PubMed ID: 14684150
[TBL] [Abstract][Full Text] [Related]
10. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
12. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
Kameoka J; Tanaka T; Nojima Y; Schlossman SF; Morimoto C
Science; 1993 Jul; 261(5120):466-9. PubMed ID: 8101391
[TBL] [Abstract][Full Text] [Related]
13. Citrullination of adenosine deaminase impairs its binding to dipeptidyl peptidase IV.
Karapetyan L; Sharoyan S; Mardanyan S; Lupidi G; Cuccioloni M; Angeletti M; Markarian S; Shilajyan H; Antonyan A
Biophys Chem; 2022 Jul; 286():106820. PubMed ID: 35468399
[TBL] [Abstract][Full Text] [Related]
14. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
15. The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed beta-propeller fold.
Hiramatsu H; Kyono K; Higashiyama Y; Fukushima C; Shima H; Sugiyama S; Inaka K; Yamamoto A; Shimizu R
Biochem Biophys Res Commun; 2003 Mar; 302(4):849-54. PubMed ID: 12646248
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.
Aertgeerts K; Ye S; Tennant MG; Kraus ML; Rogers J; Sang BC; Skene RJ; Webb DR; Prasad GS
Protein Sci; 2004 Feb; 13(2):412-21. PubMed ID: 14718659
[TBL] [Abstract][Full Text] [Related]
17. On the regulatory role of dipeptidyl peptidase IV (=CD=adenosine deaminase complexing protein) on adenosine deaminase activity.
Ben-Shooshan I; Kessel A; Ben-Tal N; Cohen-Luria R; Parola AH
Biochim Biophys Acta; 2002 May; 1587(1):21-30. PubMed ID: 12009420
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.
Engel M; Hoffmann T; Wagner L; Wermann M; Heiser U; Kiefersauer R; Huber R; Bode W; Demuth HU; Brandstetter H
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5063-8. PubMed ID: 12690074
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of human dipeptidyl peptidase IV expressed in Pichia pastoris. A structural and mechanistic comparison between the recombinant human and the purified porcine enzyme.
Bär J; Weber A; Hoffmann T; Stork J; Wermann M; Wagner L; Aust S; Gerhartz B; Demuth HU
Biol Chem; 2003 Dec; 384(12):1553-63. PubMed ID: 14719797
[TBL] [Abstract][Full Text] [Related]
20. Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity.
Gorrell MD; Abbott CA; Kähne T; Levy MT; Church WB; McCaughan GW
Adv Exp Med Biol; 2000; 477():89-95. PubMed ID: 10849733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
